Periotherapia Co., Ltd. is proud to announce our receipt of the Excellence Award at the Japan Healthcare Venture Summit (JHVS) Venture Awards 2025, organized by the Ministry of Health, Labour and Welfare.

Encouraged by this honor, we will further accelerate the research, development, and commercialization of our periostin antibody drug, a groundbreaking next-generation therapeutic.

We remain committed to living up to your expectations and earning your continued support, and we will press forward as a unified team.

JHVS Venture Awards 2025
https://mediso.mhlw.go.jp/topics_page/20250725-01/